Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Nature
|
December 17, 2025
Mazdutide versus placebo in Chinese adults with type 2 diabetes
Dalong Zhu, Jiajun Zhao, Hanqing Cai, et al.
Nature
|
December 17, 2025
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
Lixin Guo, Bo Zhang, Xia Xue, et al.
Diabetes, Obesity & Metabolism
|
December 17, 2023
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial
Yijun Li, Zhifeng Cheng, Weiping Lu, et al.
JAMA Network Open
|
August 19, 2024
GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain: A Phase 3 Randomized Clinical Trial
Xiaohui Guo, Tingting Zhang, Geheng Yuan, et al.
International Journal of Rheumatic Diseases
|
July 22, 2025
Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in Adolescents
Changgui Li, Jie Lu, Zhaohui Lyu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 9, 2025
RhTSH in aiding dynamic assessment in patients with differentiated thyroid Cancer
YanSong Lin, Qiang Wen, Wei Fu, et al.
Diabetes Care
|
November 9, 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Bo Zhang, Zhifeng Cheng, Ji Chen, et al.
The Lancet. Diabetes & Endocrinology
|
August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
Yang He, Nianrong Mi, Zhifeng Cheng, et al.
Pain and Therapy
|
May 16, 2025
Rapid Onset of Pain Relief with Crisugabalin in Patients with Diabetic Peripheral Neuropathic Pain: Findings from a Multicenter, Randomized, Double-Blind, Controlled Study
Tianrong Pan, Jianhua Ma, Yukun Li, et al.
International Journal of Rheumatic Diseases
|
July 22, 2025
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General Patients
Mingshu Sun, Zhaohui Lyu, Can Wang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Nature
|
December 17, 2025
Mazdutide versus placebo in Chinese adults with type 2 diabetes
Dalong Zhu, Jiajun Zhao, Hanqing Cai, et al.
Nature
|
December 17, 2025
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
Lixin Guo, Bo Zhang, Xia Xue, et al.
Diabetes, Obesity & Metabolism
|
December 17, 2023
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial
Yijun Li, Zhifeng Cheng, Weiping Lu, et al.
JAMA Network Open
|
August 19, 2024
GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain: A Phase 3 Randomized Clinical Trial
Xiaohui Guo, Tingting Zhang, Geheng Yuan, et al.
International Journal of Rheumatic Diseases
|
July 22, 2025
Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in Adolescents
Changgui Li, Jie Lu, Zhaohui Lyu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 9, 2025
RhTSH in aiding dynamic assessment in patients with differentiated thyroid Cancer
YanSong Lin, Qiang Wen, Wei Fu, et al.
Diabetes Care
|
November 9, 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Bo Zhang, Zhifeng Cheng, Ji Chen, et al.
The Lancet. Diabetes & Endocrinology
|
August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
Yang He, Nianrong Mi, Zhifeng Cheng, et al.
Pain and Therapy
|
May 16, 2025
Rapid Onset of Pain Relief with Crisugabalin in Patients with Diabetic Peripheral Neuropathic Pain: Findings from a Multicenter, Randomized, Double-Blind, Controlled Study
Tianrong Pan, Jianhua Ma, Yukun Li, et al.
International Journal of Rheumatic Diseases
|
July 22, 2025
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General Patients
Mingshu Sun, Zhaohui Lyu, Can Wang, et al.
Page
of 8